Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer
Clinical trial NCT03367182 · COMPLETED
Trial details
- NCT number
- NCT03367182
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-01
- Primary completion
- 2018-01-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.